Acadian Asset Management LLC Durect Corp Transaction History

Acadian Asset Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 11, 2021	SELL	$1.86 - $2.87 $1.45 Million - $2.24 Million	-779,448 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$1.65 - $2.43 $1.52 Million - $2.24 Million	-923,191 Reduced 54.22%	779,448 $1.61 Million
Q3 2020 Nov 09, 2020	BUY	$1.6 - $2.35 $467,398 - $686,491	292,124 Added 20.71%	1,702,639 $2.91 Million
Q2 2020 Aug 12, 2020	BUY	$1.33 - $2.76 $201,714 - $418,595	151,665 Added 12.05%	1,410,515 $3.27 Million
Q1 2020 May 11, 2020	BUY	$0.97 - $2.85 $118,871 - $349,261	122,548 Added 10.78%	1,258,850 $1.95 Million
Q4 2019 Feb 06, 2020	BUY	$1.69 - $3.8 $15,831 - $35,598	9,368 Added 0.83%	1,136,302 $4.32 Million
Q3 2019 Nov 07, 2019	BUY	$0.61 - $2.21 $28,415 - $102,946	46,582 Added 4.31%	1,126,934 $2.07 Million
Q2 2019 Aug 08, 2019	BUY	$0.51 - $0.86 $79,474 - $134,016	155,833 Added 16.86%	1,080,352 $705,000
Q1 2019 May 09, 2019	SELL	$0.51 - $0.82 $13,777 - $22,152	-27,015 Reduced 2.84%	924,519 $578,000
Q4 2018 Feb 07, 2019	SELL	$0.48 - $1.1 $46,152 - $105,767	-96,152 Reduced 9.18%	951,534 $459,000
Q3 2018 Oct 30, 2018	BUY	$1.06 - $1.69 $149,531 - $238,403	141,067 Added 15.56%	1,047,686 $1.15 Million
Q2 2018 Jul 24, 2018	BUY	$1.56 - $2.51 $894,294 - $1.44 Million	573,266 Added 171.97%	906,619 $1.42 Million
Q1 2018 Apr 12, 2018	BUY	$0.91 - $2.24 $303,351 - $746,710	333,353 New	333,353 $713,000

599K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $185M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.